Market Research Logo

North America and Europe Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

North America and Europe Prostate Cancer Diagnostics Market by Manufacturers, Regions, Type and Application, Forecast to 2023

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer."

Scope of the Report:
This report focuses on the Prostate Cancer Diagnostics in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain

Market Segment by Type, covers
Tumor Biomarker Tests
Imaging
Biopsy
Other

Market Segment by Applications, can be divided into
< 55
55-75
> 75

There are 19 Chapters to deeply display the North America and Europe Prostate Cancer Diagnostics market.

Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Prostate Cancer Diagnostics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Prostate Cancer Diagnostics, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;

Chapter 14, Prostate Cancer Diagnostics market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.


1 Market Overview
1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Tumor Biomarker Tests
1.2.2 Imaging
1.2.3 Biopsy
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 < 55
1.3.2 55-75
1.3.3 > 75
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genomic Health
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnostics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnostics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 OPKO
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnostics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Siemens Healthcare
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnostics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 DiaSorin
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnostics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMeriux
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnostics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnostics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 MDx Health
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnostics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Beckman Coulter
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnostics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Myriad Genetics
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnostics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Ambry Genetics
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnostics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Prostate Cancer Diagnostics Market Competition, by Manufacturer
3.1 North America and Europe Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Prostate Cancer Diagnostics Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Prostate Cancer Diagnostics Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Prostate Cancer Diagnostics Market Analysis by Countries/Regions
4.1 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Countries/Regions
4.2 North America and Europe Prostate Cancer Diagnostics Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Prostate Cancer Diagnostics Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Prostate Cancer Diagnostics Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Prostate Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Prostate Cancer Diagnostics Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Prostate Cancer Diagnostics by Type
5.1 North America and Europe Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Prostate Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
5.2 Tumor Biomarker Tests Sales Growth and Price
5.2.1 North America and Europe Tumor Biomarker Tests Sales Growth (2013-2018)
5.2.2 North America and Europe Tumor Biomarker Tests Price (2013-2018)
5.3 Imaging Sales Growth and Price
5.3.1 North America and Europe Imaging Sales Growth (2013-2018)
5.3.2 North America and Europe Imaging Price (2013-2018)
5.4 Biopsy Sales Growth and Price
5.4.1 North America and Europe Biopsy Sales Growth (2013-2018)
5.5 Other Sales Growth and Price
5.5.1 North America and Europe Other Sales Growth (2013-2018)
5.5.2 North America and Europe Other Price (2013-2018)
6 North America and Europe Market Segmentation Prostate Cancer Diagnostics by Application
6.1 North America and Europe Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
6.2 < 55 Sales Growth (2013-2018)
6.3 55-75 Sales Growth (2013-2018)
6.4 > 75 Sales Growth (2013-2018)
7 United States Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
7.2.1 United States Prostate Cancer Diagnostics Sales by Type (2013-2018)
7.2.2 United States Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
7.3 United States Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
7.3.1 United States Prostate Cancer Diagnostics Sales by Application (2013-2018)
7.3.2 United States Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
7.4 United States Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Prostate Cancer Diagnostics Export and Import (2013-2018)
8 United Kingdom Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Prostate Cancer Diagnostics Sales by Type (2013-2018)
8.2.2 United Kingdom Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
8.3 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Prostate Cancer Diagnostics Sales by Application (2013-2018)
8.3.2 United Kingdom Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
8.4 United Kingdom Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Prostate Cancer Diagnostics Export and Import (2013-2018)
9 Canada Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
9.2.1 Canada Prostate Cancer Diagnostics Sales by Type (2013-2018)
9.2.2 Canada Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
9.3 Canada Sales and Market Share by Application (2013-2018)"
"
9.3.1 Canada Prostate Cancer Diagnostics Sales by Application (2013-2018)
9.3.2 Canada Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
9.4 Canada Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Prostate Cancer Diagnostics Export and Import (2013-2018)
10 Germany Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
10.2.1 Germany Prostate Cancer Diagnostics Sales by Type (2013-2018)
10.2.2 Germany Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
10.3 Germany Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
10.3.1 Germany Prostate Cancer Diagnostics Sales by Application (2013-2018)
10.3.2 Germany Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
10.4 Germany Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Prostate Cancer Diagnostics Export and Import (2013-2018)
11 France Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
11.1 France Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
11.2 France Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
11.2.1 France Prostate Cancer Diagnostics Sales by Type (2013-2018)
11.2.2 France Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
11.3 France Sales by Application (2013-2018)"
"
11.3.1 France Prostate Cancer Diagnostics Sales by Application (2013-2018)
11.3.2 France Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
11.4 France Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
11.5 France Prostate Cancer Diagnostics Export and Import (2013-2018)
12 Italy Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
12.2.1 Italy Prostate Cancer Diagnostics Sales by Type (2013-2018)
12.2.2 Italy Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
12.3 Italy Prostate Cancer Diagnostics Sales and Market Share by Application (2013-2018)
12.3.1 Italy Prostate Cancer Diagnostics Sales by Application (2013-2018)
12.3.2 Italy Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
12.4 Italy Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Prostate Cancer Diagnostics Export and Import (2013-2018)
13 Spain Prostate Cancer Diagnostics Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Prostate Cancer Diagnostics Sales and Market Share by Type (2013-2018)
13.2.1 Spain Prostate Cancer Diagnostics Sales by Type (2013-2018)
13.2.2 Spain Prostate Cancer Diagnostics Sales Market Share by Type (2013-2018)
13.3 Spain Prostate Cancer Diagnostics Sales by Application (2013-2018)
13.3.1 Spain Prostate Cancer Diagnostics Sales by Application (2013-2018)
13.3.2 Spain Prostate Cancer Diagnostics Sales Market Share by Application (2013-2018)
13.4 Spain Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Prostate Cancer Diagnostics Export and Import (2013-2018)
14 Prostate Cancer Diagnostics Market Forecast (2018-2023)
14.1 North America and Europe Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2023)
14.2 Prostate Cancer Diagnostics Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Prostate Cancer Diagnostics Sales and Growth Rate Forecast (2018-2023)
14.3 Prostate Cancer Diagnostics Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Prostate Cancer Diagnostics Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Prostate Cancer Diagnostics Market Share Forecast by Type (2018-2023)
14.4 Prostate Cancer Diagnostics Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Prostate Cancer Diagnostics Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Prostate Cancer Diagnostics Market Share Forecast by Application (2018-2023)
15 Prostate Cancer Diagnostics Manufacturing Cost Analysis
15.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Prostate Cancer Diagnostics Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report